Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thetrahydroquinolines derivatives as bromodomain inhibitors

Thetrahydroquinolines derivatives as bromodomain inhibitors

US Patent 8580957 · Granted Nov 12, 2013

Estimated economic value: $21,202,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2023
2,3-dihydrobenzohurans as bromodomain inhibitors2022
Benzofuran derivatives and their use as bromodomain inhibitors2022
Pyrazole derivatives as bromodomain inhibitors2021
5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2021
Pyridyl derivatives as bromodomain inhibitors2021
Pyridinone dicarboxamide for use as bromodomain inhibitors2021
Pyridyl derivatives as bromodomain inhibitors2020
Pyridine dicarboxamide derivatives as bromodomain inhibitors2020
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMT2020
Benzo[b]furans as bromodomain inhibitors2020
5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS2020